Bhat Hari K, Vadgama Jaydutt V
Department of Internal Medicine, Molecular Oncology Program, Division of Laboratory Research and Development, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
Int J Mol Med. 2002 Mar;9(3):271-9.
The transport of amino acids across the plasma membrane is a process of fundamental physiological importance. If this process is modified by estrogens and if estrogen receptors play a role in this regulation, then the alteration of metabolic events will be of significant importance in cancer cells which have high estrogen receptor content because estrogens modify cellular physiology through transactivational effects of their cognate receptors. In the present study, we investigated the role of 17 beta-estradiol on the regulation of different amino acid transport systems, in particular, Systems A, ASC and y+ in estrogen receptor positive (MCF-7, T47D, H-301) and estrogen receptor negative (MCF-10, SKBR-3, MDA-MB-231) cell lines. The cells were treated with 17 beta-estradiol (10 nM), ICI 182780 (1 microM), or 17 beta-estradiol plus ICI 182780. We discovered that 17 beta-estradiol specifically stimulates System A activity by 2- to 4-fold in estrogen receptor positive cell lines with a maximal stimulation 48 h after estrogen-treatment while no stimulation was observed in estrogen receptor negative cell lines. Estrogen-dependent activation of System A was inhibited by co-treatment with the antiestrogen ICI 182780. Northern blot analysis showed that System A mRNA levels are also increased following estrogen treatment, and this induction of mRNA transcript levels by estrogen can be inhibited by co-treatment with antiestrogen ICI 182780. The increase in System A transport activity following estrogen treatment was abbrogated when estrogen receptor positive cells were stably transfected with human antisense ER alpha cDNA. Kinetic analysis demonstrated that estrogen-induced stimulation results in a doubling of Vmax with no changes in Km. However, 17 beta-estradiol did not stimulate the activation of transport systems responsible for the transport of arginine (y+) or threonine (ASC). In summary, we have provided evidence that estrogen receptors play a role in the activation of System A by estrogen. This adaptation may have important physiological and nutritional significance on estrogen dependent growth of breast tumors.
氨基酸跨质膜的转运是一个具有根本生理重要性的过程。如果这个过程受到雌激素的修饰,并且雌激素受体在这种调节中发挥作用,那么代谢事件的改变对于雌激素受体含量高的癌细胞将具有重要意义,因为雌激素通过其同源受体的反式激活作用来改变细胞生理。在本研究中,我们调查了17β-雌二醇对不同氨基酸转运系统,特别是A系统、ASC系统和y+系统在雌激素受体阳性(MCF-7、T47D、H-301)和雌激素受体阴性(MCF-10、SKBR-3、MDA-MB-231)细胞系中的调节作用。细胞用17β-雌二醇(10 nM)、ICI 182780(1 μM)或17β-雌二醇加ICI 182780处理。我们发现,17β-雌二醇在雌激素受体阳性细胞系中特异性地刺激A系统活性2至4倍,雌激素处理后48小时刺激达到最大值,而在雌激素受体阴性细胞系中未观察到刺激。与抗雌激素ICI 182780共同处理可抑制雌激素依赖性的A系统激活。Northern印迹分析表明,雌激素处理后A系统mRNA水平也升高,并且雌激素对mRNA转录水平的这种诱导可被与抗雌激素ICI 182780共同处理所抑制。当雌激素受体阳性细胞稳定转染人反义ERα cDNA时,雌激素处理后A系统转运活性的增加被消除。动力学分析表明,雌激素诱导的刺激导致Vmax加倍而Km不变。然而,17β-雌二醇并未刺激负责精氨酸(y+)或苏氨酸(ASC)转运的转运系统的激活。总之,我们提供了证据表明雌激素受体在雌激素激活A系统中发挥作用。这种适应性可能对雌激素依赖性乳腺肿瘤生长具有重要的生理和营养意义。